Prevalence and associated factors of cognitive impairment and frailty in patients with type 2 diabetes and/or obesity: The Japan Diabetes and Obesity Study 3 (J-DOS3).
AIMS Cognitive impairment and frailty in metabolic diseases remain incompletely characterized. This study aimed to determine the prevalence of cognitive decline and frailty and to examine the associations among cognitive function, frailty, and physical inactivity in adults from the Japan Diabetes and Obesity Study 3 (J...